Multiple Sclerosis – Cladribine tablets (Mavenclad)

23rd January 2018 by Louise Hudman

Multiple Sclerosis – Cladribine tablets (Mavenclad)

This is a new guideline from NICE on a new treatment for MS. Obviously we won’t be prescribing this, but I thought it worth mentioning as we may see patients starting to use it.

It is an oral medication, given as short courses (eg for 2 years, it is given for just a few days in each of a couple of months). This compares to other medications, which are either daily and continuous, or injections, or IV medications given in hospital.

It will be used as a second line treatment in relapsing-remitting MS, or in rapidly evolving severe relapsing-remitting MS.

Read more

No credit card details needed – it takes two minutes.

Join free trial


Already a member? Login to view this content.


"I would hate to have to chase practices for paying, and NASGP takes that role seriously and does an amazing job. Using a platform where that is done for me is amazing. "

Dr Tolulope Odujoko, GP, North East Essex

See the full list of features within our NASGP membership plans